Tectonic Therapeutic Inc.(TECX)今日盘中股价大跌5.11%,引发市场广泛关注。
据悉,公司近期财报数据表现不佳,营收为零、净利润亏损1772万美元、每股亏损1.20美元。这或许是导致该股大跌的主要原因。
作为一家专注于生物技术领域的公司,Tectonic一直坚持针对GPCRs靶点进行药物研发。但仍处于早期研发阶段,暂无产品上市销售。近期的疲弱财报令投资者对公司未来发展前景感到担忧,从而抛售股票造成股价暴跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.